#USA #Robbins Geller #San Diego #Class Action #Neogen Corporation

Neogen Corporation Investors: Class Action Lawsuit Notice

On July 22, 2025, Robbins Geller Rudman & Dowd LLP announced an opportunity for investors of Neogen Corporation (NASDAQ: NEOG) to lead a class action lawsuit due to substantial losses incurred between January 5, 2023, and June 3, 2025. This lawsuit focuses on potential misrepresentations made by Neogen and its executives regarding the company’s financial status and integration with 3M’s food safety division.

Overview of the Lawsuit

The law firm is inviting those who purchased Neogen common stock within the specified period to seek appointment as the lead plaintiff in this lawsuit titled Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation. Legal documentation alleges that Neogen and its executives violated the Securities Exchange Act of 1934. Interested parties must apply by September 16, 2025, to take on the role of lead plaintiff.

Allegations Against Neogen

According to the lawsuit, Neogen was involved in the development, manufacturing, and marketing of products aimed at enhancing food and animal safety. A significant event for the company was its merger with the Food Safety Division of 3M, which was announced in December 2021 and completed in September 2022. The lawsuit claims that during this period, Neogen made a series of misleading statements regarding the integration process of the two entities.

Investors were led to believe that the integration was proceeding smoothly, despite the company's internal acknowledgment of emerging issues. The lawsuit points out that even when inefficiencies were detected, Neogen management attempted to downplay these problems, assuring shareholders of their swift resolution.

Significant Financial Declines

The lawsuit details specific dates where financial mismanagement became evident:

• - On January 10, 2025, Neogen reported alarming preliminary results indicating a significant negative GAAP net income due to a hefty goodwill impairment charge related to its acquisition of 3M’s assets. This announcement jolted the market, resulting in a more than 5% drop in Neogen’s stock price.
• - Further, on April 9, 2025, Neogen revealed additional financial woes, announcing a third-quarter loss of $11 million, a stark decline from a previous year’s loss and an indication of serious operational difficulties stemming from integration problems. This revelation caused the stock to plummet by 28% in a single day.
• - Finally, by June 4, 2025, Neogen disclosed that it expected significantly lower EBITDA margins, compounded by substantial inventory write-offs that further eroded investor confidence, leading to an additional 17% drop in stock value.

The Path Forward

Under the Private Securities Litigation Reform Act of 1995, any investor affected by these developments can take steps to become the lead plaintiff. This role is pivotal, representing the financial interests of the class and guiding the lawsuit’s direction. Importantly, one does not need to assume this position to participate in any financial recovery resulting from the lawsuit.

About Robbins Geller

Robbins Geller Rudman & Dowd LLP is among the foremost law firms specializing in securities fraud and class action lawsuits aimed at seeking justice for shareholders. Recognized for achieving significant recoveries for investors, the firm boasts an impressive track record, having recovered over $2.5 billion in 2024 alone for securities-related class actions.

For more information on this class action opportunity with Neogen Corporation or to participate, interested parties may visit Robbins Geller’s dedicated page or contact attorneys J.C. Sanchez and Jennifer N. Caringal at 800-449-4900 or via email at [email protected]

As the situation is still developing, affected investors are encouraged to take action promptly to protect their interests in this class action lawsuit.